Patent AT-E401067-T1: [Translated] USE OF 4-HYDROXYTAMOXIFEN IN THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF GYNECOMASTIA
Description
The present invention provides methods for treating and preventing gynecomastia by administering 4-hydroxy tamoxifen to a patient. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with gynecomastia, this reduces the effective estrogen-androgen ratio in the breast tissue, thereby reducing ductal proliferation, epithelial and stromal hyperplasia, and pain. In patients at risk for developing gynecomastia, 4-hydroxy tamoxifen's anti-estrogenic effect prevents tissue proliferation and its accompanying pain.
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E401067-T1: [Translated] USE OF 4-HYDROXYTAMOXIFEN IN THE PRODUCTION OF A MEDICATION FOR THE TREATMENT OF GYNECOMASTIA on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401067-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem